Survival benefit of accepting livers from deceased donors over 70 years old
- PMID: 30614634
- PMCID: PMC6591042
- DOI: 10.1111/ajt.15250
Survival benefit of accepting livers from deceased donors over 70 years old
Abstract
Livers from older donors (OLDs; age ≥70) are risky and often declined; however, it is likely that some candidates will benefit from OLDs versus waiting for younger ones. To characterize the survival benefit of accepting OLD grafts, we used 2009-2017 SRTR data to identify 24 431 adult liver transplant (LT) candidates who were offered OLD grafts eventually accepted by someone. Outcomes from the time-of-offer were compared between candidates who accepted an OLD graft and matched controls within MELD ± 2 who declined the same offer. Candidates who accepted OLD grafts (n = 1311) were older (60.5 vs. 57.8 years, P < .001), had a higher median MELD score (25 vs. 22, P < .001), and were less likely to have hepatitis C cirrhosis (14.9% vs. 31.2%, P < .001). Five-year cumulative mortality among those who accepted versus declined the same OLD offer was 23.4% versus 41.2% (P < .001). Candidates who accepted OLDs experienced an almost twofold reduction in mortality (aHR:0.45 0.520.59 , P < .001) compared to those who declined the same offer, especially among the highest MELD (35-40) candidates (aHR:0.10 0.240.55 , P = .001). Accepting an OLD offer provided substantial long-term survival benefit compared to waiting for a better organ offer, notably among candidates with MELD 35-40. Providers should consider these benefits as they evaluate OLD graft offers.
Keywords: Scientific Registry for Transplant Recipients (SRTR); clinical research/practice; donors and donation: deceased; donors and donation: extended criteria; liver transplantation/hepatology; organ acceptance.
© 2019 The American Society of Transplantation and the American Society of Transplant Surgeons.
Figures
Comment in
-
A liver in the hand is worth two in the bush: Survival disadvantage of declining older liver offers.Am J Transplant. 2019 Jul;19(7):1879-1880. doi: 10.1111/ajt.15304. Epub 2019 Mar 14. Am J Transplant. 2019. PMID: 30748097 No abstract available.
References
-
- Burra P, Chirizzi L, Cardin R, Cadrobbi R, Baldan N, Calabrese F et al. Warm hepatic ischemia in pigs: effects of L-arginine and oligotide treatment. J Invest Surg 2001;14(6):303–312. - PubMed
-
- Kim WR, Lake JR, Smith JM, Skeans MA, Schladt DP, Edwards EB et al. OPTN/SRTR 2015 Annual Data Report: Liver. Am J Transplant 2017;17 Suppl 1:174–251. - PubMed
-
- Croome KP, Lee DD, Keaveny AP, Taner CB. Noneligible Donors as a Strategy to Decrease the Organ Shortage. Am J Transplant 2016. - PubMed
-
- Halazun KJ, Rana AA, Fortune B, Quillin RC 3rd, Verna EC, Samstein B et al. No country for old livers? Examining and optimizing the utilization of elderly liver grafts. Am J Transplant 2017. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical